Purchase Order 75N91018P00426

<p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for $3,825.00 on February 21, 2018, with a completion date of March 26, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for firm fixed-price scientific instruments and equipment, consistent with Li-Cor's specialization in manufacturing high-precision environmental monitoring and analytical instrumentation for federal research agencies.</p>

The National Cancer Institute issued a purchase order to Li-Cor, Inc. on June 12, 2026, for one LI-COR Biotech Odyssey M Chemi/Fluor Imaging Bundle Standard system valued at $92,376.00, with completion expected by July 12, 2026. The order is firm fixed price and carries no set-aside designation. Place of performance is Lincoln, Nebraska (the vendor's manufacturing location); delivery and installation occur at the National Cancer Institute's Laboratory of Human Carcinogenesis in Bethesda,...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>

<p>The National Cancer Institute issued a $33,983.66 delivery order to Li-Cor, Inc. on May 11, 2018, under the GSA Schedule for Scientific Equipment and Services (FSS-66).</p> <p>Li-Cor, Inc., doing business as Li-Cor Bio Sciences, is a for-profit manufacturer of scientific instruments and analysis software. Place of performance is San Diego, CA 92121. The order was priced firm fixed price with no set-aside applied. Ultimate completion date is May 10, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $4,470.04 on April 6, 2018, with completion on June 22, 2019. Work was performed in Bethesda, Maryland. The order carried firm fixed price and no set-aside designation. The source does not specify the items or services procured.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on August 5, 2015, valued at $3,011.04 for scientific instruments, reagents, or consumables with a firm fixed price structure. Performance occurred in Baltimore, Maryland, with an ultimate completion date of September 28, 2016. No set-aside applied to this simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for a LICOR Odyssey CLX imaging system with a ceiling value of $50,254.16 on September 17, 2018. Performance takes place in Lincoln, Nebraska. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for October 17, 2018. The procurement originated from a solicitation posted August 27, 2018 with a due date of September 5, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for a maintenance agreement valued at $5,250.00, effective February 14, 2018, with completion scheduled for February 21, 2019. Performance takes place in Lincoln, Nebraska. The order is a firm fixed-price maintenance agreement with no set-aside designation. Li-Cor, Inc., doing business as Li-Cor Bio Sciences, is a for-profit manufacturer of scientific instruments and analysis software.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>